Journal
NATURE IMMUNOLOGY
Volume 16, Issue 8, Pages 838-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3205
Keywords
-
Categories
Funding
- NIH
- Leonard Tow Foundation
- Greenberg Medical Research Institute
- Starr Foundation
- European Commission [EU PITN-GA-2012-316861]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712, R01AI044938] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050401, R01AR046713] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Interferon-gamma (IFN-gamma) primes macrophages for enhanced microbial killing and inflammatory activation by Toll-like receptors (TLRs), but little is known about the regulation of cell metabolism or mRNA translation during this priming. We found that IFN-gamma regulated the metabolism and mRNA translation of human macrophages by targeting the kinases mTORC1 and MNK, both of which converge on the selective regulator of translation initiation eIF4E. Physiological downregulation of mTORC1 byIFN-gamma was associated with autophagy and translational suppression of repressors of inflammation such as HES1. Genome-wide ribosome profiling in TLR2-stimulated macrophages showed thatIFN-gamma selectively modulated the macrophage translatome to promote inflammation, further reprogram metabolic pathways and modulate protein synthesis. These results show thatIFN-gamma-mediated metabolic reprogramming and translational regulation are key components of classical inflammatory macrophage activation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available